Table 8. Path model C: Association between relative risk factors.
Clinical factor | Estimate | Standard error | Test statistic | P value | Standard regression coefficient | ||
---|---|---|---|---|---|---|---|
Statin | <--> | HbA1c | 0.031 | 0.018 | 1.771 | 0.077 | 0.055 |
<--> | LDL | -5.509 | 0.552 | -9.981 | <0.001 | -0.328 | |
<--> | MDALDL | -6.691 | 0.857 | -7.806 | <0.001 | -0.251 | |
<--> | CCB | 0.047 | 0.008 | 5.99 | <0.001 | 0.19 | |
<--> | β-blocker | 0.032 | 0.007 | 4.465 | <0.001 | 0.141 | |
<--> | Antiplatelet | 0.086 | 0.008 | 10.838 | <0.001 | 0.359 | |
<--> | ACE/ARB | 0.049 | 0.008 | 6.238 | <0.001 | 0.198 | |
ACE/ARB | <--> | HbA1c | 0.036 | 0.018 | 2.05 | 0.04 | 0.064 |
<--> | LDL | -2.039 | 0.531 | -3.841 | <0.001 | -0.121 | |
<--> | MDALDL | -3.365 | 0.842 | -3.997 | <0.001 | -0.126 | |
<--> | CCB | 0.085 | 0.008 | 10.303 | <0.001 | 0.339 | |
<--> | β-blocker | 0.043 | 0.007 | 5.91 | <0.001 | 0.188 | |
<--> | Antiplatelet | 0.065 | 0.008 | 8.437 | <0.001 | 0.273 | |
Antiplatelet | <--> | HbA1c | 0.02 | 0.017 | 1.213 | 0.225 | 0.038 |
<--> | LDL | -3.524 | 0.517 | -6.823 | <0.001 | -0.218 | |
<--> | MDALDL | -6.276 | 0.823 | -7.621 | <0.001 | -0.245 | |
<--> | CCB | 0.064 | 0.008 | 8.255 | <0.001 | 0.266 | |
<--> | β-blocker | 0.049 | 0.007 | 7.082 | <0.001 | 0.226 | |
β-blocker | <--> | HbA1c | 0.019 | 0.016 | 1.216 | 0.224 | 0.038 |
<--> | LDL | -1.194 | 0.481 | -2.485 | 0.013 | -0.078 | |
<--> | MDALDL | -1.546 | 0.761 | -2.031 | 0.042 | -0.063 | |
<--> | CCB | 0.025 | 0.007 | 3.493 | <0.001 | 0.11 | |
CCB | <--> | HbA1c | -0.039 | 0.018 | -2.203 | 0.028 | -0.069 |
<--> | LDL | -2.14 | 0.531 | -4.03 | <0.001 | -0.127 | |
<--> | MDALDL | -2.952 | 0.84 | -3.515 | <0.001 | -0.11 | |
MDALDL | <--> | HbA1c | 4.21 | 1.887 | 2.231 | 0.026 | 0.07 |
<--> | LDL | 1179.82 | 67.406 | 17.503 | <0.001 | 0.652 | |
HbA1c | <--> | LDL | 0.578 | 1.188 | 0.487 | 0.627 | 0.015 |
e1 | <--> | e2 | 0.021 | 0.011 | 1.922 | 0.055 | 0.06 |
HbA1c = hemoglobin A1c; LDL = low-density lipoprotein cholesterol; MDA-LDL = malondialdehyde-modified low-density lipoprotein; CCB = calcium channel blocker; β-blocker = beta blocker; ACE = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker